CTIS.eu › Cities › France › Suresnes
Suresnes
France
212 total trials
97 recruiting
2024-520108-25-00
4
2025-11-05
Non-small cell lung cancer (NSCLC)
2025-521681-10-00
4
2025-10-02
Lung Cancer
2025-521115-40-00
4
2025-09-30
Advanced or Metastatic Non-small Cell Lung Cancer
2024-517817-34-00
9
2025-06-18
Gastric Cancer
2024-516051-40-00
4
2025-06-10
Small Cell Lung Cancer (SCLC)
2024-517818-15-00
9
2025-06-06
Non-Small Cell Lung Cancer
2024-513968-25-00
5
2025-04-28
Metastatic castration-resistant prostate cancer (mCRPC)
2023-510004-49-00
4
2025-02-18
non pretreated metastatic PAncreatic Cancer
2024-511650-50-00
5
2025-01-17
METASTATIC CASTRATION RESISTANT PROSTATE CANCER
2024-518553-41-00
5
2024-11-08
colon cancer and rectal with liver metastasis
2023-503714-77-00
4
2024-10-01
Advanced Non-Small Cell Lung Cancer
2023-507685-10-00
5
2024-05-30
High-Risk Non-muscle-invasive Bladder Cancer
2023-505515-21-00
5
2024-04-02
Giant Cell Arteritis
2022-502916-35-01
4
2024-03-27
Advanced Non-Small Cell Lung Cancer
2023-503265-27-00
5
2023-11-23
Participants with Untreated T4N0 or Stage III dMMR/MSI-H Resectable Co
2023-505107-24-00
9
2023-11-14
Non-small cell lung cancer
2022-500802-16-00
5
2023-11-01
Advanced or Metastatic PD-L1 TPS <50% Non-squamous Non-small Cell Lung
2022-501518-67-00
4
2023-08-10
High-risk and/or locally advanced prostate cancer
2022-501024-20-00
5
2023-07-25
ER+/HER2- Early Breast Cancer
2022-501027-25-01
11
2023-06-01
Multiple Sclerosis
2024-511169-12-00
5
2023-03-28
Non-Small Cell Lung Cancer
2022-501217-31-00
10
2023-03-09
Hepatocellular carcinoma
2024-514173-22-00
5
2023-02-28
Cystic Fibrosis
2024-512915-33-00
5
2022-12-22
Metastatic Colorectal Cancer
Showing 121–144 of 212 trials